It includes p53, CAGE, PGP9.5, GBU4-5, SOX2, MAGE A1, and GAGE7.The combined detection of seven serum autoantibodies has been identified as an indicator for early screening and diagnosis of lung cancer, compensating for the low sensitivity of traditional tumor markers in early-stage lung cancer. This evidence concerns the gene TP53 and neoplasm.